The 44^th JP Morgan Healthcare conference has highlighted the main theme of future of life sciences, one of which is shifting of oral medicines for obesity. This is one of the major game changes in the anti-obesity market, which will shift from weekly injectables to daily oral medicines. Eli Lilly is continuously focusing on injectable portfolio as well as showcased the advancements in its oral GLP_1 drug candidate, Orforglipron as maintenance therapy post achieving the weight loss target with its injectables. The continuous innovation and research happening in the promising market of anti-obesity is coming along with the innovations within GLP-1 market. To know more about the recent trend and future opportunities, please visit https://www.rootsanalysis.com/reports/glp-1-market.html

The newly published market report titled GLP-1 Market analysis offers a robust, data-centric perspective on how the GLP-1 industry has evolved and where it is headed through 2035. Built on credible, verified insights, the study delivers a structured review of market size, geographic expansion, and strategic behavior across stakeholders.

I recently came across a report by Roots Analysis that really put things into perspective. According to them, the GLP-1 market size, valued at USD 78 billion in 2025, is projected to reach USD 101.4 billion in 2026 and USD 180 billion by 2035, representing a CAGR of 8.7% during the forecast period 2026 to 2035.

The research highlights general factors that may be contributing to market expansion, offering a neutral and data-focused view. The GLP-1 Market forecast is based on the analysis of available information, without assigning speculative cause-and-effect reasoning to specific trends.

Report Highlights

Key Questions Answered

- What is the Market Opportunity for New Indications?
- What are the GLP-1 Market Restraints?
- Which Type of Molecules Captures the Largest GLP-1 Market Share?
- Is Oral GLP-1 Catching up with the Parenteral Version?
- Regional Analysis: Which Regions are Showing the Fastest Growth in GLP-1 Industry?
- Which Segment is Anticipated to hold the Highest Share in the Future?

• Regional Analysis:
• Company Review: Top players include AstraZeneca, Biolingus, Boehringer Ingelheim, D&D Pharmatech, Eli Lilly, Gmax Biopharm, Hanmi Pharmaceutical, Innogen, Novo Nordisk, PegBio, Pfizer, QL Biopharma, Roche, Sanofi, Sciwind Biosciences, Tonghua Dongbao Pharmaceutical, Viking Therapeutics, Vivani, vTv Therapeutic. Each profile examines regional strategy, manufacturing capacity, and product focus.

The research also explores how suppliers, distributors, and end-users engage within the current GLP-1 Market ecosystem, highlighting the operational interplay driving this market forward.

Research Integrity

• Report is prepared using a blend of primary interviews, public datasets, and proprietary databases.
• Collection of relevant data points to facilitate the process of market estimation.
• Integrating micro and macro parameters, which influence the pace of market progression
• Analyzing growth opportunities across various market segments

Need a tailored summary or extended breakdown of the data? Reach out to our team for custom insights specific to your business focus.

About Roots Analysis

Roots Analysis is a global research and consulting powerhouse specializing in Healthcare, Pharmaceutical, Biotech, Semiconductors, Chemicals and ICT industry. With over a decade of experience, they’ve supported more than 750 clients — spanning Fortune 500 companies, innovative startups, academic institutions, VCs, and strategic investors.

Why Use Roots Analysis in era of Artificial Intelligence?

• Tailored Insights
• Robust Methodology
• Smart Decisions Made Easy

By combining world-class domain expertise, careful data gathering, and dialogue with senior industry experts, Roots Analysis ensures their deliveries are trustworthy, actionable, and aligned with strategic priorities. The value proposition generated on insights generated by Roots Analysis team is unparalleled in the market research industry.

Services Offered:

• Consulting Services (custom insights supporting strategic and tactical requirements, off-the-shelf ready to consume work)

Roots Analysis offers bespoke consulting services tailored to the unique needs of clients in the life sciences and healthcare sectors.

They specialize in market assessments, tracking industry trends, dynamics, and competitive positioning. These insights help companies fine-tune their product strategies and market-entry plans.

Roots Analysis also delivers expert guidance on partnerships, licensing, and investment opportunities. Their strategic support extends to KOL identification, publication analysis, and regulatory intelligence, making them a valuable partner in business growth and innovation.

• Subscription Services (bundled services supporting multiple topics and domains for a firm)

With their subscription plans, Roots Analysis provides seamless access to a vast library of market intelligence reports. Subscribers enjoy unlimited downloads in multiple formats.

The service includes on-demand research support—allowing clients to request tailored insights and initiate custom research topics. This ensures that emerging needs are met quickly and effectively.

Each subscription comes with a dedicated account manager and direct access to analysts. Flexible billing options and tiered plans make this service suitable for organizations of all sizes seeking continuous, reliable insights.

Contact Details for Roots Analysis

Chief Executive:  Gaurav Chaudhary

Email:  Gaurav.chaudhary@rootsanalysis.com

Website: https://www.rootsanalysis.com/